Michael David Garrison - 06 Sep 2022 Form 3 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP and President Medical
Signature
Donna Kalazdy, by power of attorney for Michael Garrison
Issuer symbol
BDX
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
3
Filing time
14 Sep 2022, 11:51:30 UTC
Next filing
29 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BDX Common Stock 4,477 06 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BDX Rights to Common Stock Under BD Deferred Compensation Plan 06 Sep 2022 Common Stock 2,997 $0.000000 Direct F2
holding BDX Stock Appreciation Rights 06 Sep 2022 Common Stock 6,360 $147.68 Direct F3
holding BDX Stock Appreciation Rights 06 Sep 2022 Common Stock 3,054 $167.91 Direct F3
holding BDX Stock Appreciation Rights 06 Sep 2022 Common Stock 3,252 $222.60 Direct F3
holding BDX Stock Appreciation Rights 06 Sep 2022 Common Stock 2,801 $238.16 Direct F3
holding BDX Stock Appreciation Rights 06 Sep 2022 Common Stock 8,023 $251.06 Direct F3
holding BDX Stock Appreciation 06 Sep 2022 Common Stock 10,934 $223.77 Direct F3
holding BDX Stock Appreciation 06 Sep 2022 Common Stock 7,966 $241.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares held directly and restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person.
F3 The stock appreciation rights vest in four annual installments beginning one year from the date of grant.